GlassScriptPhysician profile
Shalin P Desai
NPI 1689841017
$31,069.49
in general payments reported to CMS, 2019-2025
45 companies · $5,624 in 2025
The $5,624 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,163 · 2020: $682 · 2021: $4,482 · 2022: $10K · 2023: $4,526 · 2024: $3,513 · 2025: $5,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,676 · Travel and Lodging: $4,888 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,676.42 |
| Travel and Lodging | $4,888.23 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,139.38 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Micra, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $3,107.58 | 2019-2025 | Versacross Connect Laac Access Solution, Watchman Flx, Emblem Mri S-Icd |
| Biotronik INC. | $1,918.88 | 2021-2024 | |
| Biosense Webster, INC. | $1,799.31 | 2025 | Carto 3 |
| Abbott Laboratories | $1,614.44 | 2021-2025 | Aveir, Agilis Hispro, Assurity |
| Medtronic Vascular, INC. | $1,172.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $966.49 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $714.86 | 2019-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $686.92 | 2021-2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $621.62 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $511.67 | 2019-2025 | |
| Amgen INC. | $499.81 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.69 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $294.64 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $202.03 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $201.03 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $198.47 | 2023-2025 | Farxiga |
| Abiomed | $184.11 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $172.34 | 2020-2022 | |
| Amarin Pharma, INC. | $158.97 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $152.82 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $150.17 | 2024 | Gemtesa |
| Novo Nordisk INC | $139.99 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Heartflow, INC. | $138.61 | 2022-2025 | Ffrct |
| Arbor Pharmaceuticals, INC. | $102.74 | 2020-2021 | |
| Philips North America LLC | $101.64 | 2023-2025 | (Ck7) Extended Holter, Mcot |
| Sanofi-Aventis U.S. LLC | $99.09 | 2019-2020 | |
| Stereotaxis INC | $83.80 | 2023 | Niobe |
| Irhythm Technologies, INC. | $74.72 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $69.77 | 2021-2024 | Nexletol |
| Impulse Dynamics (USA) INC. | $67.76 | 2024-2025 | Optimizer |
| Medicomp INC | $55.03 | 2024-2025 | Telepatch Cardiac Monitor |
| Baxter Healthcare | $46.95 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $42.55 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $36.77 | 2024 | |
| Bardy Diagnostics, INC. | $32.00 | 2020 | |
| Inspire Medical Systems, INC. | $26.17 | 2025 | Inspire |
| Recor Medical INC | $24.88 | 2024 | Paradise Renal Denervation System |
| Atricure, INC. | $22.58 | 2021 | |
| Lilly USA, LLC | $19.00 | 2025 | Zepbound, Mounjaro |
| Bridgebio Pharma, INC. | $18.36 | 2025 | Attruby |
| Vivaquant INC, Dba Rhythm Express | $16.79 | 2025 | Rhythm Express |
| Lundbeck LLC | $14.42 | 2020 | |
| Astellas Pharma US INC | $14.03 | 2019 | |
| Scpharmaceuticals INC. | $14.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalin Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.